# Daily Engineering Record: 2026-10-08

## 1. Executive Summary
- **Main Goal**: Implement Forms 16, 17, and 18 covering Embryo Transfer procedures, Endometrial Biopsy diagnostic investigations for genital tuberculosis, and Male Semen Analysis.
- **Outcome**: Successfully modeled, tested, and published all 3 clinical intake modules and interactive dashboards, expanding the active clinical forms registry to 18 forms with deep structured diagnostic parameters.

---

## 2. Completed Tasks & Forms Delivered

### 1. Form 16: Procedure Embryo Transfer (`aiims-procedure-embryo-transfer`)
- **Commit**: [`3280f9a`](file:///c:/Met4l.DSCode/Projects/open-mrs)
- **Clinical Artifact**: [`forms/aiims_procedure_embryo_transfer.json`](file:///c:/Met4l.DSCode/Projects/open-mrs/forms/aiims_procedure_embryo_transfer.json) (UUID: `80930653-7e80-4bfd-9e29-ec37c334d88f`).
- **Concept Modeling**: Registered concepts for Embryo Stage (Cleavage Day 2/3 vs Blastocyst Day 5/6), Number of Embryos Transferred, Embryo Morphology/Grade, Transfer Catheter Type (Soft vs Firm), Catheter Loading Difficulty (Easy, Moderate, Difficult), Ultrasound Guidance verification, and clinical procedure notes.
- **Frontend Architecture**: Implemented `ProcedureEmbryoTransferCard` featuring procedure metrics and catheter status.

### 2. Form 17: Investigation Female Procedure Biopsy (`aiims-investigation-female-procedure-biopsy`)
- **Commit**: [`85bf4c9`](file:///c:/Met4l.DSCode/Projects/open-mrs)
- **Clinical Artifact**: [`forms/aiims_investigation_female_procedure_biopsy.json`](file:///c:/Met4l.DSCode/Projects/open-mrs/forms/aiims_investigation_female_procedure_biopsy.json) (UUID: `80930653-7e80-4bfd-9e29-ec37c334d890`).
- **Concept Modeling**: Modeled infectious and histological evaluation of endometrial tissue: GeneXpert / CBNAAT for Mycobacterium tuberculosis (MTB Detected / Not Detected), AFB Smear & Culture, Endometrial Histopathology Examination (Chronic Endometritis, Granulomatous Endometritis, Normal), and Cavity Synechiae assessment.
- **Frontend Architecture**: Implemented `InvestigationFemaleProcedureBiopsyCard` with prominent diagnostic alerts for MTB detection.

### 3. Form 18: Investigation Male Semen (`aiims-investigation-male-semen`)
- **Commit**: [`c5e5253`](file:///c:/Met4l.DSCode/Projects/open-mrs)
- **Clinical Artifact**: [`forms/aiims_investigation_male_semen.json`](file:///c:/Met4l.DSCode/Projects/open-mrs/forms/aiims_investigation_male_semen.json) (UUID: `80930653-7e80-4bfd-9e29-ec37c334d891`).
- **Concept Modeling**: Registered WHO 6th Edition semen parameters: Ejaculate Volume (mL), Liquefaction Time, pH, Sperm Concentration (million/mL), Total Motility (%), Progressive Motility (PR %), Non-Progressive Motility (NP %), Immotile (%), Strict Normal Morphology (%), Leukocyte Count, and Diagnostic Classification (Normozoospermia, Oligozoospermia, Asthenozoospermia, Teratozoospermia, Azoospermia).
- **Frontend Architecture**: Implemented `InvestigationMaleSemenCard` displaying semen analysis values and WHO reference thresholds.

---

## 3. Architectural Decision Records (ADRs)

### ADR-001: Structured Endometrial Genital Tuberculosis Modeling
- **Context**: Genital tuberculosis is a leading cause of tubal-factor and uterine-factor infertility in India. Clinical testing involves multiple diagnostic modalities (molecular CBNAAT/GeneXpert, microbiological AFB staining, and histological biopsy).
- **Decision**: Separated each diagnostic modality into discrete coded concepts with explicit "Detected", "Not Detected", and "Inconclusive" answer sets, rather than relying on a single free-text biopsy report field.
- **Rationale**: Enables reliable clinical alerting in the patient chart when active or past endometrial TB is confirmed, directly informing clinical decisions to defer embryo transfer until completing full ATT.
- **Rejected Alternatives**:
  - *Alternative A: Single free-text "Endometrial Biopsy Findings" area.* Rejected because NLP is required to extract TB status and critical positive findings can be easily missed.
  - *Alternative B: Recording TB biopsy purely within the general Tuberculosis History form.* Rejected because endometrial biopsy is an invasive gynecological diagnostic procedure performed during fertility evaluation.

### ADR-002: WHO 6th Edition Semen Analysis Parameter Standardization
- **Context**: Semen analysis reports often mix legacy WHO 4th/5th edition classifications with modern guidelines, causing inconsistency in motility categorization (A/B/C/D vs PR/NP/IM).
- **Decision**: Modeled sperm motility strictly according to WHO 6th Edition standards (Progressive Motility %, Non-Progressive Motility %, Immotility %) with corresponding `concept_numeric` boundaries (0–100%).
- **Rationale**: Guarantees international standardization, aligns with current AIIMS Andrology laboratory protocols, and supports longitudinal tracking.
- **Rejected Alternatives**:
  - *Alternative A: Using legacy 4-grade motility (Rapid linear, Slow progressive, Non-progressive, Immotile).* Rejected because it is deprecated by WHO and obsolete in modern andrology laboratories.

---

## 4. Post-Mortems, Defect Tracking & Root Cause Analysis

### Defect 1: Numeric Precision Loss in Semen Volume
- **Root Cause**: Semen volume concept was initially defined with `allow_decimal = 0`, causing input of values like `1.5` or `2.4` mL to be truncated or rejected.
- **Resolution**: Updated `concept_numeric` for semen volume to `allow_decimal = 1` with a range of `0.1` to `15.0` mL.

---

## 5. Human-in-the-Loop Directives & Review Log
- **Human Directive 1 (GeneXpert Isolation)**: Lead Clinician required separating molecular GeneXpert MTB results from routine histopathology to immediately identify patients requiring immediate ATT referral.
- **Human Directive 2 (WHO Motility Compliance)**: Lead Embryologist mandated progressive (PR) motility as the primary numeric metric on the semen analysis card.

---

## 6. Daily Reflection & Standup Briefing Notes
1. **Forms 16, 17, and 18 Published**: Successfully delivered Embryo Transfer, Endometrial Biopsy for TB, and Semen Analysis.
2. **Standardized Infectious & Andrological Modeling**: Implemented structured GeneXpert MTB detection and WHO 6th edition semen parameters.
3. **Chart Coverage Expanded**: With andrology and biopsy integrated, the diagnostic intake phase is now fully digitized.
